We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$203M
AUM Growth
+$2.55M
Cap. Flow
+$933K
Cap. Flow %
0.46%
Top 10 Hldgs %
33.71%
Holding
98
New
7
Increased
25
Reduced
34
Closed
4

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$407K
2
COL
Rockwell Collins
COL
+$204K
3
RTX icon
RTX Corp
RTX
+$204K
4
BKH icon
Black Hills Corp
BKH
+$192K
5
ORCL icon
Oracle
ORCL
+$175K

Top Sells

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$758K
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$361K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$303K
4
JNJ icon
Johnson & Johnson
JNJ
+$233K
5
RY icon
Royal Bank of Canada
RY
+$202K

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Industrials 18.27%
3 Technology 18.23%
4 Energy 14.92%
5 Consumer Staples 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
51
IPG Photonics
IPGP
$4.1B
$973K 0.48%
13,690
+1,360
+11% +$95.5K
COP icon
52
ConocoPhillips
COP
$146B
$933K 0.46%
13,249
-60
-0.5% -$4.02K
LH icon
53
Labcorp
LH
$23.9B
$928K 0.46%
10,994
– –
TGT icon
54
Target
TGT
$61.1B
$670K 0.33%
11,070
+1,755
+19% +$104K
MCD icon
55
McDonald's
MCD
$187B
$621K 0.31%
6,340
– –
EPZM
56
DELISTED
Epizyme, Inc
EPZM
$569K 0.28%
25,000
-25,000
-50% -$758K
TT icon
57
Trane Technologies
TT
$106B
$549K 0.27%
9,586
-200
-2% -$11.9K
CI icon
58
Cigna
CI
$75.7B
$543K 0.27%
6,480
– –
PFE icon
59
Pfizer
PFE
$142B
$531K 0.26%
17,423
– –
PSX icon
60
Phillips 66
PSX
$83B
$495K 0.24%
6,407
– –
STT icon
61
State Street
STT
$50.6B
$456K 0.22%
6,554
-38
-0.6% -$2.63K
KMB icon
62
Kimberly-Clark
KMB
$35.6B
$444K 0.22%
4,203
– –
NEE icon
63
NextEra Energy
NEE
$187B
$425K 0.21%
17,760
– –
BAX icon
64
Baxter International
BAX
$11.2B
$400K 0.2%
10,011
– –
CSX icon
65
CSX Corp
CSX
$98.1B
$336K 0.17%
34,800
– –
ALNY icon
66
Alnylam Pharmaceuticals
ALNY
$35.9B
$320K 0.16%
4,758
-4,662
-49% -$361K
GIS icon
67
General Mills
GIS
$19B
$316K 0.16%
6,100
-188
-3% -$9.31K
SJT
68
San Juan Basin Royalty Trust
SJT
$118M
$313K 0.15%
17,750
– –
CAT icon
69
Caterpillar
CAT
$412B
$300K 0.15%
3,024
– –
LLY icon
70
Eli Lilly
LLY
$1.06T
$276K 0.14%
4,700
– –
NGG icon
71
National Grid
NGG
$82B
$267K 0.13%
4,017
– –
APC
72
DELISTED
Anadarko Petroleum
APC
$258K 0.13%
3,040
– –
T icon
73
AT&T
T
$159B
$255K 0.13%
9,632
– –
COL
74
DELISTED
Rockwell Collins
COL
$207K 0.1%
+2,594
New +$204K
BDBD
75
DELISTED
BOULDER BRANDS INC
BDBD
$202K 0.1%
11,450
-4,750
-29% -$73K
1 2
3
4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Brian C. Broderick's Q1 2014 Portfolio in Review

As of Q1 2014, Brian C. Broderick held 98 positions worth $203M, up 1.3% from $201M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brian C. Broderick's Q1 2014 filing shows 7 new, 25 increased, 34 reduced and 4 closed positions. Its largest new stake was Rockwell Collins: 2,594 shares worth $207K. The largest sale was Epizyme, Inc, an estimated $758K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q1 2014 buy was Rockwell Collins: 2,594 shares worth $207K.
  • Brian C. Broderick added most to Qualcomm in Q1 2014, an estimated $407K increase.
  • Brian C. Broderick's biggest Q1 2014 reduction was Epizyme, Inc, cutting an estimated $758K.
  • Brian C. Broderick fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $303K.
  • Brian C. Broderick's ten largest holdings make up 34% of its $203M portfolio in Q1 2014.
  • Brian C. Broderick opened 7 new positions and closed 4 in Q1 2014.
  • Brian C. Broderick's portfolio value rose 1.3% quarter-over-quarter to $203M.

Based on Brian C. Broderick's 13F filing for Q1 2014, filed 29 May 2014.